BioCentury | Dec 11, 2020
Emerging Company Profile

Launching with $81M, Third Rock’s Faze is latest biotech seeking to unravel biomolecular condensates biology

...Rock partner emeritus and SAB member, and Faze co-founder Ronald Vale about repeat expansion disorder pathogenesis.Meyers...
BioCentury | Jun 13, 2020
Management Tracks

Sawyers to head AACR next year; plus Quell, CalciMedica, Bigfoot, Celyad, Praxis, Affimed and more

...on April 9-14. Sawyers is chair of Memorial Sloan Kettering Cancer Center’s human oncology and pathogenesis...
BioCentury | Apr 9, 2020
Tools & Techniques

NCI takes lead on serological test validation as cancer center joins COVID-19 fight

...samples. The goals are to identify therapeutic targets, gain insights into the biology of COVID-19 pathogenesis...
BioCentury | Feb 28, 2020
Product Development

WHO reports China making 1.6M COVID-19 diagnostic kits per week, describes therapy and vaccine R&D priorities

...development of therapies and vaccines. “The ideal animal model for studying routes of virus transmission, pathogenesis...
BioCentury | Feb 1, 2020
Preclinical News

Preclinical Roundup: CureVac gets CEPI funding for 2019 coronavirus; plus blockade of CD47-SIRPA for atherosclerosis, Stanford and IBM-CDHI

...and reduced plaque size and vascular inflammation. Single-cell algorithm predicts cell differentiation paths, including in pathogenesis...
BioCentury | Jan 25, 2020
Emerging Company Profile

Aluda: targeting the fundamentals

...Genentech Inc. with the goal of discovering novel compounds that target fundamental processes associated with pathogenesis...
...for the protein. Co-founder and COO Deebie Symmes said ALD-R491 addresses the four “cornerstones” of pathogenesis...
BioCentury | Dec 17, 2019

ELK1 overexpression for Huntington disease

...normalized expression of genes that are dysregulated in HD and have been implicated in disease pathogenesis...
BioCentury | Nov 19, 2019

Reducing ER stress through USP14 inhibition could treat diabetes

...by reducing the effects of endoplasmic reticulum stress, which has been implicated in the disease’s pathogenesis...
BioCentury | Oct 4, 2019
Company News

Icosavax’s self-assembling vaccine platform

...Tokyo:4502; NYSE:TAK). Its SAB also includes Barney Graham, deputy director and chief of the Viral Pathogenesis...
BioCentury | Sep 4, 2019
Financial News

Second megaround of ‘19 to help Passage broaden rare CNS disease pipeline

...failure” in the therapeutic area. Passage is going after rare monogenic diseases in which the pathogenesis...
Items per page:
1 - 10 of 509
BioCentury | Dec 11, 2020
Emerging Company Profile

Launching with $81M, Third Rock’s Faze is latest biotech seeking to unravel biomolecular condensates biology

...Rock partner emeritus and SAB member, and Faze co-founder Ronald Vale about repeat expansion disorder pathogenesis.Meyers...
BioCentury | Jun 13, 2020
Management Tracks

Sawyers to head AACR next year; plus Quell, CalciMedica, Bigfoot, Celyad, Praxis, Affimed and more

...on April 9-14. Sawyers is chair of Memorial Sloan Kettering Cancer Center’s human oncology and pathogenesis...
BioCentury | Apr 9, 2020
Tools & Techniques

NCI takes lead on serological test validation as cancer center joins COVID-19 fight

...samples. The goals are to identify therapeutic targets, gain insights into the biology of COVID-19 pathogenesis...
BioCentury | Feb 28, 2020
Product Development

WHO reports China making 1.6M COVID-19 diagnostic kits per week, describes therapy and vaccine R&D priorities

...development of therapies and vaccines. “The ideal animal model for studying routes of virus transmission, pathogenesis...
BioCentury | Feb 1, 2020
Preclinical News

Preclinical Roundup: CureVac gets CEPI funding for 2019 coronavirus; plus blockade of CD47-SIRPA for atherosclerosis, Stanford and IBM-CDHI

...and reduced plaque size and vascular inflammation. Single-cell algorithm predicts cell differentiation paths, including in pathogenesis...
BioCentury | Jan 25, 2020
Emerging Company Profile

Aluda: targeting the fundamentals

...Genentech Inc. with the goal of discovering novel compounds that target fundamental processes associated with pathogenesis...
...for the protein. Co-founder and COO Deebie Symmes said ALD-R491 addresses the four “cornerstones” of pathogenesis...
BioCentury | Dec 17, 2019

ELK1 overexpression for Huntington disease

...normalized expression of genes that are dysregulated in HD and have been implicated in disease pathogenesis...
BioCentury | Nov 19, 2019

Reducing ER stress through USP14 inhibition could treat diabetes

...by reducing the effects of endoplasmic reticulum stress, which has been implicated in the disease’s pathogenesis...
BioCentury | Oct 4, 2019
Company News

Icosavax’s self-assembling vaccine platform

...Tokyo:4502; NYSE:TAK). Its SAB also includes Barney Graham, deputy director and chief of the Viral Pathogenesis...
BioCentury | Sep 4, 2019
Financial News

Second megaround of ‘19 to help Passage broaden rare CNS disease pipeline

...failure” in the therapeutic area. Passage is going after rare monogenic diseases in which the pathogenesis...
Items per page:
1 - 10 of 509